Lagari Violet S, Al-Yatama Fatima, Rodriguez Gracielena, Berger Hara R, Levis Silvina
Division of Endocrinology, Diabetes, and Metabolism, University of Miami Miller School of Medicine, 1400 NW 10th Ave Suite 807 Miami, FL 33136, USA.
Endocrinology Section, Miami Veterans Affairs Healthcare System, 1201 NW 16th St (11GRC), Miami, FL 33125, USA.
Geriatrics (Basel). 2019 Jan 9;4(1):9. doi: 10.3390/geriatrics4010009.
After the first fracture, the risk of subsequent fractures increases significantly. Medical treatment can reduce the risk of a second fracture by about 50%, but many older adults do not receive osteoporosis medication following their first fracture. This observational study aimed to understand primary care management patterns of older adults after osteoporotic fractures at the Miami Veterans Affairs (VA) Healthcare System. A retrospective review of 219 fracture cases selected by International Classification of Disease (ICD-9) codes between October 2015 and September 2016 identified 114 individuals age ≥50 years who had a non-traumatic fracture code entered in their medical record for the first time. Among them, 72 (63%) did not undergo a bone mineral density (BMD) test or receive treatment in the 12 months following their fracture. Of the 40 individuals who had a BMD test post-fracture, 17 (100%) received or were considered for anti-osteoporosis treatment if their T-score indicated osteoporosis (T-score ≤-2.5), but only 8/23 (35%) if the T-score was >-2.5. Physicians are more likely to prescribe osteoporosis therapy based on a BMD T-score diagnosis of osteoporosis, rather than a clinical diagnosis of osteoporosis based on a low-trauma fracture. A change in practice patterns is necessary to decrease the incidence of fractures.
首次骨折后,后续骨折的风险会显著增加。医学治疗可将二次骨折的风险降低约50%,但许多老年人在首次骨折后并未接受骨质疏松症药物治疗。这项观察性研究旨在了解迈阿密退伍军人事务(VA)医疗系统中老年人骨质疏松性骨折后的初级保健管理模式。对2015年10月至2016年9月期间根据国际疾病分类(ICD-9)编码选出的219例骨折病例进行回顾性分析,确定了114名年龄≥50岁且首次在病历中录入非创伤性骨折编码的个体。其中,72人(63%)在骨折后的12个月内未进行骨密度(BMD)检测或接受治疗。在骨折后进行了BMD检测的40人中,如果T值表明患有骨质疏松症(T值≤-2.5),17人(100%)接受了或被考虑接受抗骨质疏松治疗,但如果T值>-2.5,只有8/23(35%)的人接受了治疗。医生更倾向于根据BMD T值诊断的骨质疏松症来开骨质疏松症治疗药物,而不是基于低创伤骨折的临床诊断。有必要改变实践模式以降低骨折发生率。